Advanced search
Publication Cover
Clinical Ophthalmology Volume 13, 2019 - Issue
Submit an article Journal homepage
318
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Treatment of central serous chorioretinopathy with topical NSAIDs

Sepehr Bahadorani1 Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
,
Kyle Maclean1 Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
,
Kendall Wannamaker1 Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
,
Edward Rickie Chu1 Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
,
Nathan Gresores2 Medical Center Ophthalmology Associates, San Antonio, TX, USA
,
Jeong-Hyeon Sohn1 Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
,
Roberto Diaz-Rohena1 Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
&
Michael A Singer2 Medical Center Ophthalmology Associates, San Antonio, TX, USACorrespondence[email protected]
 show all
Pages 1543-1548 | Published online: 15 Aug 2019

References

  • Nicholson BP, Atchison E, Idris AA, Bakri SJ. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. Surv Ophthalmol. 2018;63(1):1–8. doi:10.1016/j.survophthal.2017.06.008
  • Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41(2):201–214. doi:10.1111/j.1442-9071.2012.02848.x
  • Okushiba U, Takeda M. Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography. Nihon Ganka Gakkai Zasshi. 1997;101(1):74–82.
  • Liegl R, Ulbig MW. Central serous chorioretinopathy. Ophthalmologica. 2014;232(2):65–76. doi:10.1159/000360014
  • Caccavale A, Romanazzi F, Imparato M, Negri A, Morano A, Ferentini F. Central serous chorioretinopathy: a pathogenetic model. Clin Ophthalmol. 2011;5:239–243. doi:10.2147/OPTH.S17182
  • Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P. Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev. 2015;22(12):CD011841.
  • Iacono P, Battaglia Parodi M, Falcomatà B, Bandello F. Central serous chorioretinopathy treatments: a mini review. Ophthalmic Res. 2015;55(2):76–83. doi:10.1159/000441502
  • Abouammoh MA. Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol. 2015;29(4):278–286. doi:10.1016/j.sjopt.2015.01.007
  • Schwartz R, Habot-Wilner Z, Martinez MR, et al. Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study. Acta Ophthalmol. 2017;95(7):e610–e618. doi:10.1111/aos.13273
  • Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing snellen visual acuity measurements. Retina. 2010;30(7):1046–1050. doi:10.1097/IAE.0b013e3181d87e04
  • Sander B, Al-Abiji HA, Kofod M, Jørgensen TM. Do different spectral domain OCT hardwares measure the same? Comparison of retinal thickness using third-party software. Graefes Arch Clin Exp Ophthalmol. 2015;253(11):1915–1921. doi:10.1007/s00417-015-3075-2
  • Alkin Z, Osmanbasoglu OA, Ozkaya A, Karatas G, Yazici AT. Topical nepafenac in treatment of acute central serous chorioretinopathy. Med Hypothesis Discov Innov Ophthalmol. 2013;2(4):96–101.
  • Khan NA, Atiqa K, Sobia K, Aisha K, Ahmed AK. Topical Bromfenac in the Treatment of Central Serous Chorioretinopathy. Adv Ophthalmol Vis Syst. 2017;7(7):00248.
  • McCafferty S, Harris A, Kew C, et al. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmol. 2017;17(1):16. doi:10.1186/s12886-017-0405-7
  • Artunay O, Senel A, Sengul A, Rasier R, Bahcecioglu H. Central serous chorioretinopathy associated with topical latanoprost therapy. Ocul Immunol Inflamm. 2011;19(6):453–455. doi:10.3109/09273948.2011.619680
  • Ayhan Tuzcu E, Keskin U, Coskun M, Ilhan O, Daglıoglu M, Oksuz H. Bilateral serous detachment associated with latanoprost/timolol fixed combination use: a report of one phakic case. Case Rep Ophthalmol Med. 2012;2012:305379.
  • Caccavale A, Imparato M, Romanazzi F, Negri A, Porta A, Ferentini F. A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy. Med Hypotheses. 2009;73(3):435–437. doi:10.1016/j.mehy.2009.03.036
  • Kutyrina IM, Androsova SO, Warshavskii VA, Tareyeva IE. Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis. Nephron. 1982;32(3):244–248. doi:10.1159/000182853
  • Pedrinelli R, Arzilli F, Cavasinni L, Poli L, Sassano P, Salvetti A. The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension. J Endocrinol Invest. 1978;1(4):315–320. doi:10.1007/BF03350976
  • Cakir B, Fischer F, Ehlken C, et al. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016;254(11):2151–2157. doi:10.1007/s00417-016-3373-3
  • Gong Q, Sun XH, Yuan ST, Liu QH. The relation of the serum aldosterone level and central serous chorioretinopathy - a pilot study. Eur Rev Med Pharmacol Sci. 2017;21(3):446–453.
  • Bucolo C, Marrazzo G, Platania CB, Romano GL, Drago F, Salomone S. Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation. J Pharm Pharmacol. 2014;66(7):954–960. doi:10.1111/jphp.12224
  • Bucolo C, Drago F, Salomone S. Ocular drug delivery: a clue from nanotechnology. Front Pharmacol. 2012;3:188. doi:10.3389/fphar.2012.00188

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.